Real-time enrollment status for this b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 12:00 PM UTC
| NCT Number | NCT06649812 |
| Recruiting Status | Recruiting |
| Condition | B-cell Lymphoma |
| Phase | PHASE2 |
| Target Enrollment | 120 participants |
| Active Locations | 114 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | October 14, 2026 (Yesterday) |
As of October 15, 2026: Clinical trial NCT06649812 is currently recruiting participants. This phase2 study for b-cell lymphoma is actively seeking new participants at 114 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06649812 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 114 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06649812 was last updated Yesterday (October 14, 2026). HelloStudys verifies this status automatically.